
Peter Pitts: Drug price controls lead to higher costs, fewer choices
Democrats are declaring the Biden administration’s first round of price caps on prescription drugs a victory for patients. But neither the price controls nor other drug provisions under the 2022 Inflation Reduction Act are anything to celebrate.






















